New bone formation in axial spondyloarthritis

Joint Bone Spine

Volumn 80, Issue 5, 2013, Pages 454-458

  Wendling, Daniel ^a   Claudepierre, Pascal ^b  

^a CHRU de Besançon ^*  (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Ankylosing spondylitis; Magnetic resonance imaging; New bone formation; Nonsteroidal antiinflammatory drugs; Radiography; Spondyloarthritis; Syndesmophyte; TNF antagonists

Indexed keywords

ADALIMUMAB; BONE MORPHOGENETIC PROTEIN; C REACTIVE PROTEIN; CYTOKINE; ETANERCEPT; GROWTH FACTOR; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; SCLEROSTIN; STROMELYSIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; WNT PROTEIN;

ANKYLOSING SPONDYLITIS; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LONGITUDINAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; OSTEONEOGENESIS; PREDICTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SACROILIAC JOINT; SHORT SURVEY; SPINE; SPINE RADIOGRAPHY; SPONDYLARTHRITIS; TREATMENT OUTCOME;

ANKYLOSING SPONDYLITIS; MAGNETIC RESONANCE IMAGING; NEW BONE FORMATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RADIOGRAPHY; SPONDYLOARTHRITIS; SYNDESMOPHYTE; TNFΑ ANTAGONISTS;

DISEASE PROGRESSION; HUMANS; OSSIFICATION, HETEROTOPIC; SPONDYLARTHRITIS;

EID: 84885937367     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.02.004     Document Type: Short Survey

References (45)

1. Rudwaleit M., Taylor W.J. Classification criteria for psoriatic arthritis and ankylosing spondylitis/axial spondyloarthritis. Best Pract Res Clin Rheumatol 2010, 24:589-604.
2. Claudepierre P., Voisin M.C. The entheses: histology, pathology, and pathophysiology. Joint Bone Spine 2005, 72:32-37.
3. Wendling D., Toussirot E., Streit G., et al. Imaging study scores for ankylosing spondylitis. Joint Bone Spine 2006, 73:655-660.
4. Chary-Valckenaere I., d'Agostino M.A., Loeuille D. Role for imaging studies in ankylosing spondylitis. Joint Bone Spine 2011, 78:138-143.
5. Brophy S., Mac Kay K., Al-Saidi A., et al. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 2002, 29:1236-1243.
6. Baraliakos X., Listing J., Rudwaleit M., et al. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 2007, 66:910-915.
7. Van der Heijde D., Landewé R., Van der Linden S. How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?. Arthritis Rheum 2005, 52:1979-1985.
8. Baraliakos X., Listing J., von der Recke A., et al. The natural course of radiographic progression in ankylosing spondylitis-evidence for major individual variations in a large proportion of patients. J Rheumatol 2009, 36:997-1002.
9. Braem K., Lories R.J. Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models. Joint Bone Spine 2012, 79:243-248.
10. Carter S., Braem K., Lories R.J. The role of bone morphogenetic proteins in ankylosing spondylitis. Ther Adv Musculoskel Dis 2012, 4:293-299.
11. Lories R.J.U., Luyten F.P., de Vlam K. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther 2009, 11:221.
12. Santos A., Bakker A.D., Willems H.M., et al. Mechanical loading stimulates BMP7, but not BMP2, production by osteocytes. Calcif Tissue Int 2011, 89:318-326.
13. Bonewald L.F., Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 2008, 42:606-615.
14. van Tubergen A., Ramiro S., van der Heijde D., et al. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study. Ann Rheum Dis 2012, 71:518-523.
15. Maksymowych W.P., Landewé R., Conner-Spady B., et al. Serum matrix metalloproteinase3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 2007, 56:1846-1853.
16. Brophy S., Mackay K., Al-Saidi A., et al. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 2002, 29:1236-1243.
17. Vosse D., Landewé R., Garnero P., et al. Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2years follow-up in patients with ankylosing spondylitis. Rheumatology (Oxford) 2008, 47:1219-1222.
18. Ward M.M., Hendrey M.R., Malley J.D., et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum 2009, 61:859-866.
19. Poddubnyy D., Haibel H., Listing J., et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012, 64:1388-1398.
20. Chung H.Y., Machado P., van der Heijde D., et al. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis 2012, 71:809-816.
21. Appel H., Ruiz-Heiland G., Listing J., et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 2009, 60:3257-3262.
22. Heiland G.R., Appel H., Poddubnyy D., et al. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 2012, 71:572-574.
23. Chen H.A., Chen C.H., Lin Y.J., et al. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol 2010, 37:2126-2132.
24. Baraliakos X., Listing J., Rudwaleit M., et al. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008, 10:R104.
25. Maksymowych W.P., Chiowchanwisawakit P., Clare T., et al. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009, 60:93-102.
26. van der Heijde D., Machado P., Braun J., et al. MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis 2012, 71:369-373.
27. Chiowchanwisawakit P., Lambert R.G., Conner-Spady B., et al. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 2011, 63:2215-2225.
28. Pedersen S.J., Chiowchanwisawakit P., Lambert R.G., et al. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J Rheumatol 2011, 38:1349-1354.
29. Pedersen S.J., Sørensen I.J., Lambert R.G., et al. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Arthritis Rheum 2011, 63:3789-3800.
30. Wanders A., Heijde D., Landewé R., et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005, 52:1756-1765.
31. Kroon F., Landewé R., Dougados M., et al. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2012, 71:1623-1629.
32. Poddubnyy D., Rudwaleit M., Haibel H., et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 2012, 71:1616-1622.
33. Haroon N., Shen H., Carty A., et al. Continuance of non-steroidal anti-inflammatory drugs may reduce radiographic progression in ankylosing spondylitis patients on biological therapy. Arthritis Rheum 2011, 63:1303.
34. Haroon N., Kim T.H., Inman R.D. NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms?. Ann Rheum Dis 2012, 71:1593-1595.
35. Baraliakos X., Listing J., Brandt J., et al. Radiographic progression in patients with ankylosing spondylitis after 4years of treatment with the anti-TNF-alpha antibody infliximab. Rheumatology (Oxford) 2007, 46:1450-1453.
36. van der Heijde D., Landewé R., Einstein S., et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 2008, 58:1324-1331.
37. van der Heijde D., Landewé R., Baraliakos X., et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008, 58:3063-3070.
38. van der Heijde D., Salonen D., Weissman B.N., et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2years. Arthritis Res Ther 2009, 11:R127.
39. Schett G., Landewé R., van der Heijde D. Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?. Ann Rheum Dis 2007, 66:709-711.
40. Sieper J., Appel H., Braun J., et al. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 2008, 58:649-656.
41. Claudepierre P., Wendling D. Are inflammation and ossification on separate tracks in ankylosing spondylitis?. Joint Bone Spine 2008, 75:520-522.
42. Lories R.J., Dougados M. Inflammation and ankylosis: still an enigmatic relationship in spondyloarthritis. Ann Rheum Dis 2012, 71:317-318.
43. Maksymowych W.P., Elewaut D., Schett G. Motion for debate: the development of ankylosis in ankylosing spondylitis is largely dependent on inflammation. Arthritis Rheum 2012, 64:1713-1719.
44. Maksymowych W.P., Morency N., Conner-Spady B., et al. Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification. Ann Rheum Dis 2013, 72:23-28.
45. Wendling D., Prati C., Claudepierre P., et al. Non-radiographic spondyloarthritis: a theoretical concept or a real entity?. Joint Bone Spine 2012, 79:531-533. 10.1016/j.jbspin.2012.06.009.